Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
Dr. Geoffrey Donnan discusses the main takeaways from his study on thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. Read his NEJM article here: https://www.nejm.org/doi/pd...
29 Heinä 20192min
Continuum Pearls: Disease-Modifying Therapies in MS
Dr. Robert H. Gross discusses disease-modifying therapies in MS in the third part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Diseas...
25 Heinä 20191min
Continuum Pearls: Disease-Modifying Therapies in MS, pt. 2
Dr. Robert H. Gross discusses disease-modifying therapies in MS in the second part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Disea...
24 Heinä 20193min
Determining clinically meaningful decline in preclinical Alzheimer disease
Dr. Philip Insel provides the main findings of his paper on determining clinically meaningful decline in preclinical Alzheimer disease.
23 Heinä 20191min
Targeting Huntington Expression in Patients with Huntington's Disease
Dr. Sarah Tabrizi discusses the main findings of her study on targeting Huntington expression in patients with Huntington's Disease. Ready the May 6th article in NEJM: https://www.nejm.org/doi/full/10...
22 Heinä 20191min
Continuum Pearls: Disease-Modifying Therapies in MS
Dr. Robert H. Gross discusses disease-modifying therapies in MS in the first part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Diseas...
19 Heinä 20192min
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial, pt. 2
Prof. Gil Wolfe discusses who might and might not be good candidates for thymectomy for non-thymomatous myasthenia gravis in the second part of his interview with Dr. Ted Burns. Read the full study in...
17 Heinä 20193min
The full spectrum of epilepsies from SUDEP in the North American SUDEP Registry
Dr. Orrin Devinsky summarizes his paper on the full spectrum of epilepsies and the North American SUDEP Registry. Listen to this week's full podcast for the entire interview.
16 Heinä 20192min
